-
-
-
-
-
-
-
Wolf Haldenstein Adler Freeman & Herz LLP is investigating P3 Health Partners, Inc.
-
-
-
-
-
-
-
BTIG Reiterates Neutral Rating on P3 Health Partners Inc (PIII)
-
-
-
-
-
-
-
P3 Health Partners Announces Third Quarter 2024 Results
-
-
-
-
-
-
-
P3 Health Partners Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
-
-
-
-
-
-
P3 Health Partners to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
-
-
-
-
-
-
-
P3 Health Partners Announces Second-Quarter 2023 Results
-
-
-
-
-
-
-
P3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 Results
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

